SES
10.4.2018 18:02:11 CEST | Business Wire | Press release
Following major space and ground infrastructure investments and the expansion of its Latin America video neighbourhood, SES today announced the launch of its Ultra HD platform into the region to accelerate commercial 4K rollouts among leading cable, IPTV, and DTH providers across Latin America.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180410006195/en/
Many of Latin America’s leading Pay TV providers are already testing SES’s new Ultra HD solution, an all-in-one package of pre-configured Ultra HD content, reception equipment, and satellite distribution that will enable quick and easy Ultra HD deployments over the region. The new SES Latin America Ultra HD solution will open with four Ultra HD channels, including NASA TV UHD, produced by Harmonic, as well as the SES Ultra HD demo channel, an incubator for emerging 4K content producers. SES plans to add new channels and content produced in Brazil, Mexico, and other Latin American countries in the future.
Like SES’s North America Ultra HD solution, the end-to-end Latin America platform will be distributed over multiple SES satellites. SES-6 will provide dedicated delivery across 100% of the Brazilian market, offering programming flexibility for local content. SES’s NSS-806 satellite, home to SES’s leading Latin American Pay TV neighbourhood, will serve the rest of the region until it is replaced by the recently launched SES-14 satellite later this year. Once SES-14 initiates service, SES plans to significantly expand the Latin America channel lineup on its expanding video neighbourhood at 47.5 West. SES is the unmatched leader in global HD and Ultra HD distribution, and has experienced unprecedented 18% year-on-year growth in Latin America with over 300 HD and Ultra HD channels currently hosted on its satellites.
“SES is ushering in an exciting new era of advanced television services across the region with the launch of our new Latin America Ultra HD platform – the latest game-changing solution built on SES’s robust network of space and ground infrastructure. The SES network is enabling the efficient delivery of HD, Ultra HD, and OTT content to audiences throughout the region,” said Jurandir Pitsch, Vice President, Sales and Market Development for SES Video in Latin America and the Caribbean. “Latin America’s leading Pay TV providers are poised to offer Ultra HD content to their subscribers via the SES platform ahead of the 2018 World Cup, which is driving strong interest in 4K services across the region.”
The SES-backed antenna programme, which led to the installation of satellite antennas at Pay TV distribution hubs throughout Latin America, puts SES in a prime position to help cable, IPTV and DTH providers reach 100% of the region’s vast audiences with advanced HD and Ultra HD content.
Learn more about the SES UHD platform
Follow us on:
About SES
SES is the world-leading satellite operator and the first to deliver a differentiated and scalable GEO-MEO offering worldwide, with more than 50 satellites in Geostationary Earth Orbit (GEO) and 16 in Medium Earth Orbit (MEO). SES focuses on value-added, end-to-end solutions in two key business units: SES Video and SES Networks. The company provides satellite communications services to broadcasters, content and internet service providers, mobile and fixed network operators, governments and institutions. SES’s portfolio includes ASTRA, O3b and MX1, a leading media service provider that offers a full suite of innovative digital video and media services. SES is listed on the Euronext Paris and Luxembourg Stock Exchange (ticker: SESG). Further information available at: www.ses.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20180410006195/en/
Contact:
SES
Markus Payer
Corporate Communications & PR
Tel.
+352 710 725 500
Markus.Payer@ses.com
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 11:47:00 CEST | Press release
The program has involved over 1,100 startups across 50+ countries, delivering 26 pilot projects. Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food prod
JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 10:16:00 CEST | Press release
JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 08:00:00 CEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom